- Home
- FRPH vs BBNX Comparison
FRPH vs BBNX Comparison
Compare FRPH & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRPH | BBNX |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | 423 |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.3M | 493.1M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | FRPH | BBNX |
|---|---|---|
| Price | $21.60 | $10.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $26.22 |
| AVG Volume (30 Days) | 64.4K | ★ 957.6K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $41,774,000.00 | N/A |
| Revenue This Year | N/A | $34.99 |
| Revenue Next Year | N/A | $34.47 |
| P/E Ratio | $135.88 | ★ N/A |
| Revenue Growth | ★ 0.65 | N/A |
| 52 Week Low | $20.53 | $8.89 |
| 52 Week High | $29.68 | $32.71 |
Technical Indicators
Market Signals| Indicator | FRPH | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 37.23 |
| Support Level | N/A | $9.91 |
| Resistance Level | $24.59 | $15.53 |
| Average True Range (ATR) | 0.73 | 0.59 |
| MACD | -0.07 | 0.29 |
| Stochastic Oscillator | 37.14 | 46.02 |
Price Performance
Historical ComparisonAbout FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.